- Trials with a EudraCT protocol (774)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (330)
774 result(s) found for: Eye Disease.
Displaying page 20 of 39.
EudraCT Number: 2015-000736-15 | Sponsor Protocol Number: GLH694-P001 | Start Date*: 2015-09-14 | ||||||||||||||||
Sponsor Name:Alcon Research, Ltd. | ||||||||||||||||||
Full Title: Additive Effect of Twice Daily Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue | ||||||||||||||||||
Medical condition: Ocular Hypertension Open-angle Glaucoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) ES (Completed) GB (Completed) FR (Completed) GR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003816-21 | Sponsor Protocol Number: RDG-10298 | Start Date*: 2012-01-11 | ||||||||||||||||
Sponsor Name:S.A. Alcon-Couvreur N.V | ||||||||||||||||||
Full Title: Multi-Center Study Assessing Efficacy and Tolerability of TRAVATAN® Solution without BAK, containing Polyquad® Preservative (0.004% travoprost) in Patients Previously on latanoprost 0.005% or bimat... | ||||||||||||||||||
Medical condition: Open angle Glaucoma Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) SE (Completed) ES (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003119-13 | Sponsor Protocol Number: 14/0172 | Start Date*: 2015-02-11 | ||||||||||||||||
Sponsor Name:Joint Research Office- UCL | ||||||||||||||||||
Full Title: Can simvastatin significantly reduce the amount of immunosuppressive medication required by patients with sight threatening uveitis? A phase IIb, single site, randomized, placebo controlled, double... | ||||||||||||||||||
Medical condition: Uveitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-012564-13 | Sponsor Protocol Number: Cystadrops®/09/choc-study | Start Date*: 2013-01-03 | |||||||||||
Sponsor Name:Orphan Europe SARL | |||||||||||||
Full Title: Cysteamine Hydrochloride for nephropathic Cystinosis, open-label Phase III pivotal study | |||||||||||||
Medical condition: Nephropatic cystinosis patients with cystine corneal deposits | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004982-28 | Sponsor Protocol Number: FFIS/PG/2017/03 | Start Date*: 2018-05-23 |
Sponsor Name:Fundación para la Formación e Investigación Sanitarias de la Región de Murcia | ||
Full Title: Phase IIb prospective, unicentric, randomized, parallel, double-blind, placebo-controlled clinical trial to evaluate the intravenous infusion of prostaglandins as therapy in patients with non-arter... | ||
Medical condition: Non-arteritic anterior ischemic optic neuropathy (NOIANA). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002395-75 | Sponsor Protocol Number: NSR-REP-02 | Start Date*: 2018-01-17 | |||||||||||
Sponsor Name:NightstaRx Ltd (A Biogen Company) | |||||||||||||
Full Title: An Open-Label Safety Study of Retinal Gene Therapy for Choroideremia with Bilateral, Sequential Administration of Adeno-Associated Viral Vector (AAV2) Encoding Rab Escort Protein 1 (REP1) | |||||||||||||
Medical condition: Choroideremia (CHM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002531-15 | Sponsor Protocol Number: 09/0959 | Start Date*: 2016-11-14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:UCL Comprehensive Clinical Trials Unit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A phase II, open label, non-randomised, single centre, clinical trial of ANX776 in Healthy Volunteers and patients with Glaucoma, Age-Related Macular Degeneration, and Optic Neuritis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Glaucoma, Age-related Macular Degeneration, and Optic Neuritis. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-004766-16 | Sponsor Protocol Number: C-05-10 | Start Date*: 2006-02-17 |
Sponsor Name:Alcon Research, Ltd. | ||
Full Title: Comparison of Safety and Efficacy of Brinzolamide/Timolol Fixed Combination vs COSOPT in Patients with Open-Angle Glaucoma or Ocular Hypertension | ||
Medical condition: Open Angle Glaucoma or Ocular Hypertension ICD: H40.1/H40.0 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) BE (Completed) GB (Completed) LT (Completed) LV (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-015681-55 | Sponsor Protocol Number: C-09-023 | Start Date*: 2010-03-18 | ||||||||||||||||
Sponsor Name:Alcon Research, Ltd. | ||||||||||||||||||
Full Title: A Dose-Escalation Study of AL-39324 Suspension versus Lucentis™ for the Treatment of Exudative Age-Related Macular Degeneration | ||||||||||||||||||
Medical condition: Exudative Age-related macular degeneration | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-001215-37 | Sponsor Protocol Number: RG_16_211 | Start Date*: 2018-03-19 |
Sponsor Name:University of Birmingham | ||
Full Title: A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome | ||
Medical condition: Wolfram syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) PL (Ongoing) FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003193-17 | Sponsor Protocol Number: BAY86-5321/17514 | Start Date*: 2016-08-30 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: A multi center, single arm, interventional Phase 4 study to evaluate a Treat and Extend regimen of intravitreal aflibercept for treatment of macular edema secondary to central retinal vein occlusion | |||||||||||||
Medical condition: Macular edema secondary to CRVO | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) DK (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002611-99 | Sponsor Protocol Number: 20090 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: Open-label, randomized, two–arm, controlled study to assess the efficacy, safety, and tolerability of intravitreal (IVT) aflibercept compared to laser photocoagulation in patients with retinopathy ... | |||||||||||||
Medical condition: Retinopathy of prematurity | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SE (Completed) NL (Completed) PT (Completed) GB (GB - no longer in EU/EEA) BE (Completed) DE (Completed) SK (Completed) AT (Completed) BG (Completed) PL (Completed) ES (Completed) HU (Completed) LT (Completed) EE (Completed) LV (Completed) GR (Completed) IT (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001092-14 | Sponsor Protocol Number: TIGEM5_USH | Start Date*: 2023-10-12 | ||||||||||||||||
Sponsor Name:FONDAZIONE TELETHON | ||||||||||||||||||
Full Title: A phase I/II open label, dose escalation study of sub-retinal administration of a “mixture of two adeno-associated viral vectors of serotype 8 containing the 5 ´- half sequence of the human MYO7A ... | ||||||||||||||||||
Medical condition: Usher syndrome (USH) is characterized by the association of sensorineural hearing loss, Retinitis Pigmentosa (RP), and, in some cases, vestibular dysfunction. It is the most frequent cause of deaf-... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005081-19 | Sponsor Protocol Number: 1 | Start Date*: 2014-07-10 | |||||||||||
Sponsor Name:HOSPICES CIVILS DELYON | |||||||||||||
Full Title: Phase II study evaluating the efficacy of aflibercept for the treatment of idiopathic choroidal neovascularization in young subjects: the INTUITION study | |||||||||||||
Medical condition: idiopathic choroidal neovascularization | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004416-35 | Sponsor Protocol Number: OFT-EDE-2016 | Start Date*: 2017-04-21 | |||||||||||
Sponsor Name:Fundació Parc Taulí | |||||||||||||
Full Title: Efficacy and safety of three regimens based on tobramycin, dexamethasone and diclofenac for the prevention of pseudophakic macular edema. Randomized clinical trial | |||||||||||||
Medical condition: Pseudophakic macular edema is a pathology that results from cataract surgery, usually occurring 4-6 weeks after surgery, which directly affects the retina (specifically the macula, the region that ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001247-51 | Sponsor Protocol Number: v.1/040312 | Start Date*: 2012-06-04 | |||||||||||||||||||||
Sponsor Name:Mika Harju | |||||||||||||||||||||||
Full Title: | |||||||||||||||||||||||
Medical condition: | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FI (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-019975-30 | Sponsor Protocol Number: 35131 | Start Date*: 2010-08-24 | ||||||||||||||||
Sponsor Name:University Medical Center, Johannes Gutenberg-University Mainz | ||||||||||||||||||
Full Title: Investigation of the efficacy and safety of preoperative IOP reduction with preservative-free COSOPT-S® (dorzolamide/timolol, MSD) eye drops versus oral acetazolamide and dexamethasone eye drops an... | ||||||||||||||||||
Medical condition: Patients with glaucoma requiring trabeculectomy (filtration surgery) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014612-34 | Sponsor Protocol Number: CRFB002APT02T | Start Date*: 2011-09-12 | |||||||||||
Sponsor Name:AIBILI - Association for Innovation and Biomedical Research on Light and Image | |||||||||||||
Full Title: Prospective, multicenter, open-label study to evaluate the safety and efficacy of intravitreal ranibizumab in patients with subfoveal or juxtafoveal choroidal neovascularization (CNV) secondary to ... | |||||||||||||
Medical condition: Patients with subfoveal or juxtafoveal choroidal neovascularization secondary to other causes than Age-related Macular Degeneration and Pathological Myopia (angioid streaks, pseudohistoplasmosis, i... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001469-28 | Sponsor Protocol Number: SA2008 | Start Date*: 2009-06-17 | |||||||||||
Sponsor Name:Dep. of Ophthalmology, Medical University of Vienna | |||||||||||||
Full Title: A randomized, double-masked study with intraocular Bevacizumab (Avastin®) compared with intravitreal Ranibizumab (Lucentis®) in patients with persistent diabetic macular edema or persistent active ... | |||||||||||||
Medical condition: persistent diabetic macula edema or persistent diabetic proliferative retinopathy after lasercoagulation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005875-10 | Sponsor Protocol Number: VGFTe-ROP-2036 | Start Date*: 2022-03-10 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals. Inc. | |||||||||||||
Full Title: An Extension Study to Evaluate the Long-Term Outcomes of Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study | |||||||||||||
Medical condition: Retinopathy of prematurity (ROP) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.